fbpx
Medical Innovation Exchange

Exelixis signs on $25M to check out 3 drug targets from BioInvent's antibody library

https://www.fiercebiotech.com/biotech/exelixis-forks-over-25m-licensing-rights-potential-bioinvent-antibody-drug-targets

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.